ASX:TLXBiotechs
Is Telix (ASX:TLX) Using Vertical Integration To Quietly Redefine Its Radiopharmaceutical Moat?
In late June 2026, Telix Pharmaceuticals held a special call highlighting continued commercial traction for its radiopharmaceutical portfolio, growing international reach, and ongoing clinical and partnership progress in precision oncology.
An interesting takeaway is the use of vertical integration and deal-making across manufacturing and distribution to strengthen Telix’s position as a global radiopharmaceutical competitor.
We’ll now explore how this emphasis on vertical integration and...